cayman chemical bpc-157 (Body Protection Compound) Bacteriostatic Water | Research

Bacteriostatic Water | Research Diluent & Handling Guide

Its research profile centres on actin regulation, angiogenesis, and cell migration—all of which are key to tissue repair

DNA HEALTH

Strength:5mg

In its lawsuit, the OFA said that the FDA’s decision to end the shortage was a “reckless” and “arbitrary” move and could “deprive patients of a vital treatment for type 2 diabetes and obesity.” In an interview with BioSpace last month, David Rosen, partner at Foley & Lardner, said that the lawsuit “is a precedent in this area.” Prior to the OFA suit, “no one has ever challenged the FDA’s decision to remove a therapy from the drug shortage list.” The OFA case is still ongoing, with the next court update due on Thursday